Dosimetric benefits of hemigland stereotactic body radiotherapy for prostate cancer: implications for focal therapy

OBJECTIVE: Compared with standard, whole-gland (WG) therapies for prostate cancer, focal approaches may provide equivalent oncologic outcomes with fewer adverse effects. The purpose of this study was to compare organ-at-risk (OAR) dosimetry between hemigland (HG) and WG stereotactic body radiotherap...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Radiol
Autors principals: Kishan, Amar U, Park, Sang J, King, Christopher R, Roberts, Kristofer, Kupelian, Patrick A, Steinberg, Michael L, Kamrava, Mitchell
Format: Artigo
Idioma:Inglês
Publicat: The British Institute of Radiology. 2015
Matèries:
Full Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4984947/
https://ncbi.nlm.nih.gov/pubmed/26463234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1259/bjr.20150658
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars